Incidence and Management of Retinopathy and Uveitis in Patients Receiving BRAF/MEK Inhibitor Therapy

VKH-like uveitis was found to be significantly more frequent in patients with melanoma than in those with other malignancies.

Authors

Institutions

Publication Details

Journal
Seminars in Ophthalmology
Published
2025-02-24
DOI
https://doi.org/10.1080/08820538.2025.2468381
Citations
3
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
2.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incidence and Management of Retinopathy and Uveitis in Patients Receiving BRAF/MEK Inhibitor Therapy

Isana Nakajima, Hideki Tsuji, Koji Yoshino
3 citations
Seminars in Ophthalmology
Melanoma and MAPK Pathways
2.42
article

Incidence and Management of Retinopathy and Uveitis in Patients Receiving BRAF/MEK Inhibitor Therapy

Isana Nakajima, Hideki Tsuji, Koji Yoshino
article en
3 citations

Abstract

VKH-like uveitis was found to be significantly more frequent in patients with melanoma than in those with other malignancies.

Seminars in OphthalmologyVol. 40(8)
The Cancer Institute Hospital (JP), Japanese Foundation For Cancer Research (JP)
Good health and well-being
Openalex Percentile: Top 13%
Melanoma and MAPK Pathways
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Incidence and Management of Retinopathy and Uveitis in Patients Receiving BRAF/MEK Inhibitor Therapy — Isana Nakajima, Hideki Tsuji, et al. · Seminars in Ophthalmology (2025) | TGRS Research Map | TGRS